Ephedra , from the plant Ephedra sinica , has been used as a herbal remedy in traditional Chinese medicine for 5,000 years for the treatment of asthma and hay fever, as well as for the common cold. Known in Chinese as ma huang (simplified Chinese: 麻黄 ; traditional Chinese: 麻黃 ; pinyin: má huáng), ephedra is a stimulant which constricts blood vessels and increases blood pressure and heart rate. Several additional species belonging to the genus Ephedra have traditionally been used for a variety of medicinal purposes, and are a possible candidate for the Soma plant of Indo-Iranian religion. Native Americans and Mormon pioneers drank a tea brewed from an Ephedra, called Mormon Tea , but North American ephedras lack the alkaloids found in species such as E. sinica .
Ephedra-containing dietary supplements have been linked to a high rate of serious side effects and a number of deaths, leading to concern from the U.S. Food and Drug Administration (FDA), the National Center for Complementary and Alternative Medicine, and the medical community. However, initial efforts to test and regulate ephedra were defeated by lobbying and political pressure from the dietary-supplement industry. Ultimately, in response to accumulating evidence of adverse effects and deaths related to ephedra, the FDA banned the sale of ephedra-containing supplements on April 12, 2004.
Following a legal challenge by an ephedra manufacturer, the U.S. Court of Appeals for the Tenth Circuit upheld the FDA's ban of ephedra in 2006. The sale of ephedra-containing dietary supplements remains illegal in the United States due to evidence of adverse ephedra-related effects. Following the FDA's ban, the supplement industry has marketed "ephedrine-free" or "legal" ephedra products, in which the ephedra is replaced with other herbal stimulants such as bitter orange.
Biochemistry and pharmacology
The alkaloids ephedrine and pseudoephedrine are the active constituents of the plant. Pseudoephedrine is used in over-the-counter decongestants. Derivatives of ephedrine are used to treat low blood pressure, but alternatives with reduced cardiovascular risk have replaced it for treating asthma. Ephedrine is also considered a performance-enhancing drug and is prohibited in most competitive sports. Some species in the Ephedra genus have no alkaloid content; however, the most commonly used species, E. sinica , has a total alkaloid content of 1–3% by dry weight. Ephedrine constitutes 40–90% of the alkaloid content, with the remainder consisting of pseudoephedrine and the demethylated forms of each compound.
Effects and uses
Ephedra is both a stimulant and a thermogenic; its biological effects are due to its ephedrine and pseudoephedrine content. These compounds stimulate the brain, increase heart rate, constrict blood vessels (increasing blood pressure), and expand bronchial tubes (making breathing easier). Their thermogenic properties cause an increase in metabolism, evidenced by an increase in body heat.
In traditional Chinese herbology, E. sinica is included in many herbal formulas used to treat cold and flu such as 麻黃湯 ma huang tang (ephedra decoction) or 麻杏石甘湯 ma xing shi gan tang (ephedra, apricot kernel, gypsum, and licorice decoction). Ephedra is used therapeutically as a diaphoretic to help expel exterior pathogens and regulate the proper functioning of the lungs.
Ephedra is widely used by athletes, despite a lack of evidence that it enhances athletic performance. Ephedra may also be used as a precursor in the illicit manufacture of methamphetamine.
Ephedra has also been used for weight loss, sometimes in combination with aspirin and caffeine (known as an ECA stack). Some studies have shown that ephedra, when taken in a regulated and supervised environment, is effective for marginal short-term weight loss (0.9 kg/month more than the placebo), although it is unclear whether such weight loss is maintained. However, several reports have documented the large number of adverse events attributable to unregulated ephedra supplements.
Side effects of ephedra may include severe skin reactions, hypertension, irritability, nervousness, dizziness, trembling, headache, insomnia, profuse perspiration, dehydration, itchy scalp and skin, vomiting, hyperthermia, irregular heartbeat, seizures, heart attack, stroke, or death.
Purity and dosage
There are no formal requirements for standardization or quality control of dietary supplements in the United States, and the dosage of effective ingredients in supplements may vary widely from brand to brand or batch to batch. Studies of ephedra supplements have found significant discrepancies between the labeled dose and the actual amount of ephedra in the product. Significant variation in ephedrine alkaloid levels, by as much as 10-fold, was seen even from lot to lot within the same brand.
Safety and regulatory actions in the United States
Escalating concerns regarding the safety of ephedra supplements led the FDA to ban the sale of ephedra-containing supplements in the United States in 2004. This ban was challenged by supplement manufacturers and initially overturned, but ultimately upheld.
Initial concerns and supplement industry response
In 1997, in response to mounting concern over serious side effects of ephedra, the FDA proposed a ban on products containing 8 mg or more of ephedrine alkaloids and stricter labeling of low-dose ephedra supplements. The FDA also proposed that ephedra labels be required to disclose known health risks of ephedra, such as heart attack, stroke, or death.
In response, the supplement industry created a public relations group, the Ephedra Education Council, to lobby against the labeling requirements, and commissioned a scientific review by a private consulting firm, which reported that ephedra was safe. The Ephedra Education Council also attempted to block publication of a study confirming wide discrepancies between the labeled potency of supplements and the actual amount of ephedra in the product.
During this time, Metabolife, makers of the best-selling brand of ephedra supplement, had received over 14,000 complaints of adverse events associated with its product; these reports were not provided to the FDA. Senators Orrin Hatch and Tom Harkin, authors of the Dietary Supplements Health and Education Act, questioned the scientific basis for the FDA's proposed labeling changes, arguing that the reported problems were insufficient to warrant regulatory action. At the time, Hatch's son was working for a firm hired to lobby Congress and the FDA on behalf of ephedra manufacturers.
In addition to the activities of the Ephedra Education Council, Metabolife spent more than $4 million between 1998 and 2000 lobbying against state regulation of ephedra in Texas. Business Week reported that efforts to regulate ephedra and other potentially harmful supplements had been "beaten down by deep-pocketed industry lobbying." Ultimately, in 2000, the FDA withdrew the proposed labeling changes and restrictions.
Additional evidence
A review of ephedra-related adverse reactions, published in the New England Journal of Medicine in 2000, found a number of cases of sudden cardiac death or severe disability resulting from ephedra use, many of which occurred in young adults using ephedra in the labeled dosages. Subsequently, in response to pressure from the consumer advocacy group Public Citizen, Metabolife was compelled by the Department of Justice in 2002 to turn over reports of over 15,000 ephedra-related adverse events, ranging from insomnia to death, which the company had previously withheld from the FDA. Use of ephedra was considered to have possibly contributed to the death of Minnesota Vikings offensive lineman Korey Stringer from heatstroke in 2001.
Death of Steve Bechler
Steve Bechler, a pitcher for the Baltimore Orioles, died of complications from heatstroke following a spring training workout on February 17, 2003. The medical examiner found that ephedra toxicity played a "significant role" in Bechler's sudden death. Following Bechler's death, the FDA re-opened its efforts to regulate ephedra use. According to Bruce Silverglade, legal director for the Center for Science in the Public Interest, "All of a sudden Congress dropped objections to an ephedra ban and started demanding the FDA act."
Senator Orrin Hatch, who in 1999 had helped block the FDA's attempts to regulate ephedra, said in March 2003 that "it has been obvious to even the most casual observer that problems exist," and called FDA regulation of ephedra "long overdue." Given Hatch's prior defense of ephedra, Time described his statement as "a dazzling display of hypocrisy."
Ephedra banned
In response to renewed calls for the regulation of ephedra, the FDA commissioned a large meta-analysis of ephedra's safety and efficacy by the RAND Corporation. This study found that while ephedra promoted modest short-term weight loss, there was no evidence that it was effective for long-term weight loss or performance enhancement. The use of ephedra in this study was associated with significant gastrointestinal, psychiatric, and autonomic side effects. Almost simultaneously, a study in Annals of Internal Medicine found that ephedra was 100 to 700 times more likely to cause a significant adverse reaction than
3 Strongest Slimming Diet Pills Review– Best Slimming Diet Pills
Reviews of Slimming Pills, Diet Pills and Fat Burners. What is the Best Slimming Pill ... this "super-vitamin", DecaSlim users report ... Consumer fear that Fenphedra could soon be ...
4 Strongest Diet Pills That Really Work – Best Diet Pill Reviews
ResearchDietPills.com provides diet pill research, expert opinion, and consumer ... Which Diet Pills Work Best… Confused? Don’t be, here ... is the "NATURAL HIGH" that users report ...
Diet Pill Reviews - What Are The Best Diet Pills? Which Diet Pills ...
Years of Diet Pill Reviews and thousands of real consumer feedback has led us to this point - Our ... I don't know if Apidexin is really the best diet pill and cannot report on any ...
Adipex Tablets No Prescription Fernandes Bernadett - Boxes and Arrows ...
best weight loss adipex diet pill adipex diet pills online pharmacy buying adipex online without a ... consumer report adderall adipex adipex without a prescription needed cheap ...
Consumerpricewatch.net - Consumer Price Watch - Top 10 Diet Pills ...
The best diet pills based on the following 12-Point criteria are ... Consumer Price Watch) ... Consumer Price - Index | Consumer Price Report | Consumer ...
What's the best energy pill? - Yahoo! Answers
What's the best energy pill? 1 year ago; Additional ... did you buy the 8 hr energy pills? Report Abuse ... 10 Diet Pills Reviewed Consumer's Pick the Top Diet Pills Now ...
Are diet pills effective?
And even if you do drop a few pounds using diet pills, the ... weight-loss drug sibutramine (Meridia) produces, at best ... Consumer Reports.org | Cars | Appliances | Home & Garden | ...
Finding The Best Diet Pill Reviews | Health Area
Home >Diet, Info health products >Finding The Best Diet Pill Reviews ... Consumer reviews will often report side effects experienced, and it is through these reports that ...
adipex_online_a62m - WSBTV Upload and Share Member
consumer report adderall adipex adipex ebay adipex no prescription ... diet adipex detox best price on adipex health food adipex diet pill no prescription needed for adipex
Top best weight loss pills review
Proven Diet Products - Best diet pills review. Our site will provide ... to the U.S. Surgeon General report ... OUR #1 BEST RATED CONSUMER WEIGHT LOSS DIET PRODUCT